Medications

Upadacitinib beats placebo for psoriatic arthritis

For patients with psoriatic arthritis, upadacitinib at a dose of 15 mg or 30 mg once daily is more effective than placebo, according to a study published in the April 1 issue of the New England Journal of Medicine.

Arthritis & Rheumatism

Pharmacovigilance needed for rheumatology patients

(HealthDay)—Recommendations have been developed for pharmacovigilance in rheumatology, emphasizing the need for continued monitoring of new drugs, according to a position statement issued by the American College of Rheumatology ...

Arthritis & Rheumatism

Studies reveal looming shortage of rheumatologists

Two new articles provide insights on the outlook of rheumatology in the United States, noting that the need for rheumatologists will greatly exceed the projected growth of the rheumatology workforce over the next 15 years. ...

Arthritis & Rheumatism

Funding, mentors critical for academic rheumatology careers

(HealthDay)—Funding and division/department support are ranked as critical factors in enabling rheumatologists to develop a career in academic research, according to a study published in the September issue of Arthritis ...

page 5 from 17